6 results

145 Five years of the CiPA project (2013–2018): what did we learn?
Dong-Seok Yim
Transl Clin Pharmacol. 2018;26(4):145-149.   Published online 2018 December 19    DOI: http://dx.doi.org/10.12793/tcp.2018.26.4.145
150 Pharmacodynamic principles and target concentration intervention
Nick Holford
Transl Clin Pharmacol. 2018;26(4):150-154.   Published online 2018 December 19    DOI: http://dx.doi.org/10.12793/tcp.2018.26.4.150
155 Regulatory innovation for expansion of indications and pediatric drug development
Min Soo Park
Transl Clin Pharmacol. 2018;26(4):155-159.   Published online 2018 December 19    DOI: http://dx.doi.org/10.12793/tcp.2018.26.4.155
160 Prediction of the human in vivo antiplatelet effect of S- and R-indobufen using population pharmacodynamic modeling and simulation based on in vitro platelet aggregation test
Yook-Hwan Noh, Sungpil Han, Sangmin Choe, Jin-Ah Jung, Jin-Ah Jung, Ae-Kyung Hwang, Hyeong-Seok Lim
Transl Clin Pharmacol. 2018;26(4):160-165.   Published online 2018 December 19    DOI: http://dx.doi.org/10.12793/tcp.2018.26.4.160
166 Development of a user-friendly training software for pharmacokinetic concepts and models
Seunghoon Han, Byounghee Lim, Hyemi Lee, Soo Hyun Bae
Transl Clin Pharmacol. 2018;26(4):166-171.   Published online 2018 December 19    DOI: http://dx.doi.org/10.12793/tcp.2018.26.4.166
172 Trends of clinical trials from 2014 to 2016 in South Korea
Ki Young Huh, Jun Gi Hwang, SeungHwan Lee
Transl Clin Pharmacol. 2018;26(4):172-176.   Published online 2018 December 19    DOI: http://dx.doi.org/10.12793/tcp.2018.26.4.172
Articles from Translational and Clinical Pharmacology are provided here courtesy of Korean Society for Clinical Pharmacology and Therapeutics